TY  - CONF

T1  - Dupilumab treatment normalizes skin barrier function and improves patient-reported outcomes in patients aged 6 to 11 years with moderate-to-severe atopic dermatitis

JO  - JOURNAL OF INVESTIGATIVE DERMATOLOGY

PY  - 2023/01/01

AU  - Cork MJ

AU  - Leung DYM

AU  - Ong P

AU  - Danby SG

AU  - Ramirez-Gama M

AU  - Garcia S

AU  - Taylor P

AU  - Zahn J

AU  - Praestgaard A

AU  - Bologna G

AU  - Zhang A

ED  - 

VL  - 143

IS  - 11

SP  - S342

EP  - S342

Y2  - 2024/12/22

ER  -